Get to know us

We develop our products with a clear line of sight from scientific opportunity to patient benefit. Patient safety, product quality, scientific rigor, and regulatory compliance are non-negotiable. Beyond these foundations, however, we are prepared to question established assumptions and challenge conventional approaches whenever they limit innovation or patient value.

We change what must be changed and invent where gaps need to be filled. In doing so, we look for solutions wherever they can be found. Some originate within the pharmaceutical industry, others emerge from entirely different disciplines. We believe meaningful innovation often occurs at the intersection of fields rather than within their traditional boundaries.

Our goal is not to challenge convention for its own sake. Our goal is to achieve better outcomes for patients, healthcare systems, and society.

Our team

Our strength lies in the diversity of our backgrounds, experiences, and perspectives. Together, we bring decades of expertise spanning pharmaceutical research, development, safety, regulation, diagnostics, business development, and commercialization across the entire healthcare value chain.

As a team, we combine scientific rigor, operational experience, entrepreneurial thinking, and a shared commitment to improving patient outcomes through innovative medicines.

For good reasons, Triquetra Medicines has always been—and remains—a majority women-led company.

Katerina Chinenyeze

Co-Founder, COO and Operational Lead

Experienced Patient Safety scientist with expertise in biomedical and cognitive sciences and more than 13 years of pharmaceutical industry experience.

Katerina combines scientific rigor, operational leadership, and organizational excellence with a strong focus on innovation and execution.

Steffen Ernst

Co-Founder, CEO and CMO

Physician, Board-certified Toxicologist, Patient Safety expert, entrepreneur, and business leader with more than 25 years of pharmaceutical industry experience spanning research, development, safety, and commercialization.

Steffen combines scientific leadership, strategic thinking, and extensive cross-functional experience across the pharmaceutical value chain.

Helge Lubenow

Co-Founder/CFO and BD Lead

Biologist, geneticist, and experienced business development leader with extensive entrepreneurial and strategic leadership experience across the pharmaceutical and diagnostics industries.

Helge brings a unique ability to connect science, business development, and finance, helping translate innovation into sustainable commercial opportunities.

PD. Dr. Antje Wick

PD Dr. Antje Wick is Head of the Heidelberg University Hospital Headache Clinic and an attending neuro-oncologist at Heidelberg University Hospital and the National Center for Tumor Diseases, Heidelberg, Germany.

An internationally recognized expert in headache medicine and neuro-oncology, Dr. Wick provides independent clinical expertise and strategic guidance to the development of TRQ001.

Dr. Jenny Royle

Dr. Jenny Royle is founder of Rekaryo and MediPaCe Ltd and is based in the United Kingdom. She holds a PhD in Pharmacology from the University of Cambridge and additional qualifications in Psychology and Behaviour Change.

Drawing on extensive experience in Clinical Development, Clinical Sciences, Regulatory Affairs, Patient Safety, and Public Health, Dr. Royle provides strategic guidance on patient-centered development and stakeholder engagement for TRQ001.

Dr. Peter-Christoph Schulz

Dr. Peter-Christoph Schulz is Senior Vice President, Pharmacovigilance and Quality at EXPLIC8 in Lucerne, Switzerland.

With more than 25 years of pharmaceutical industry experience, Dr. Schulz brings extensive expertise in drug safety, pharmacovigilance, quality systems, and risk management. He provides strategic support to the development of TRQ001.

Our invaluable Advisors (Scientifc Advisory Board)

Dominik Aue CFA

Dominik Aue is a Swiss financial professional with more than 12 years of experience supporting innovative and high-growth companies. His expertise spans corporate finance, capital strategy, fundraising, and business development across multiple industries.

As a trusted advisor to Triquetra Medicines, Dominik contributes strategic financial guidance and entrepreneurial insight, helping translate long-term vision into sustainable growth and execution.

Our indispensable financial counselor

Triquetra Medicines AB

Triquetra Medicines AB is a private limited company incorporated in Sweden with registered number 559219-9888. Triquetra Medicines™ is an EU-registered trademark.